Metastatic cancer

Common Name(s)

Metastatic cancer

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Metastatic cancer" returned 3813 free, full-text research articles on human participants. First 3 results:

Subacute headache in a patient with metastatic gastric cancer.
 

Author(s): Kathleen E Batley, Henning Schade, W Thomas Purcell, E David Crawford

Journal: Oncology (Williston Park, N.Y.). 2015 May;29(5):390, C3.

 

Last Updated: 18 May 2015

Go To URL
Treatment of HER2-positive metastatic breast cancer.
 

Author(s): Sandra M Swain, Emma Clark, José Baselga

Journal: N. Engl. J. Med.. 2015 May;372(20):1964-5.

 

Last Updated: 14 May 2015

Go To URL
Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial).
 

Author(s): M Yoshida, K Muro, A Tsuji, Y Hamamoto, T Yoshino, K Yoshida, K Shirao, Y Miyata, D Takahari, T Takahashi, A Ohtsu

Journal: Eur. J. Cancer. 2015 May;51(8):935-41.

 

Chemotherapeutic regimens for elderly patients with metastatic colorectal cancer (mCRC), such as bevacizumab combined with 5-fluorouracil (5-FU) and leucovorin, often exclude oxaliplatin and irinotecan owing to the risk of toxicity. However, treatment with infusional 5-fluorouracil ...

Last Updated: 2 May 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Metastatic cancer" returned 386 free, full-text review articles on human participants. First 3 results:

Radium-223 in Bone-Metastatic Prostate Cancer: Current Data and Future Prospects.
 

Author(s): Brian Lewis, Elie Chalhoub, Carla Chalouhy, Oliver Sartor

Journal: Oncology (Williston Park, N.Y.). 2015 Jul;29(7):483-8.

 

Ra-223 (radium-223) is an alpha particle-emitting radiopharmaceutical with targeted uptake in areas of osteoblastic lesions. The combination of targeted skeletal uptake, short tissue-penetration range, and high energy of alpha particles allows for targeted cell killing and a low toxicity ...

Last Updated: 16 Jul 2015

Go To URL
Reducing Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer.
 

Author(s): Julie N Graff, Tomasz M Beer

Journal: Oncology (Williston Park, N.Y.). 2015 Jun;29(6):416-23.

 

Skeletal-related events contribute substantially to morbidity, mortality and cost in men with metastatic castration-resistant prostate cancer (mCRPC). There are five agents available for treatment in mCRPC that reduce skeletal-related events. Here we discuss the efficacy and safety ...

Last Updated: 20 Jun 2015

Go To URL
Targeted therapies for ER+/HER2- metastatic breast cancer.
 

Author(s): Mutsuko Yamamoto-Ibusuki, Monica Arnedos, Fabrice André

Journal:

 

The majority of breast cancers present with estrogen receptor (ER)-positive and human epidermal growth factor receptor (HER2)-negative features and might benefit from endocrine therapy. Although endocrine therapy has notably evolved during the last decades, the invariable appearance ...

Last Updated: 10 Jun 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
 

Status: Recruiting

Condition Summary: Metastatic Cancer; Metastatic Melanoma; Renal Cancer

 

Last Updated: 3 Apr 2015

Go to URL
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
 

Status: Recruiting

Condition Summary: Metastatic Cancer; Pancreatic Cancer; Mesothelioma; Ovarian

 

Last Updated: 30 May 2015

Go to URL

Last Updated: 20 Apr 2015

Go to URL